AbbVie

Bayer, Ferring International and AbbVie were among the most highly active sponsors with 21, 11 and seven trials, respectively

The growth is drive by an increasing number of aesthetic procedures, technological advancements, growing urban population,…

The NASH market will undergo a very rapid growth, at a compound annual growth rate (CAGR) of 68.8 per cent from 2019 to 2029

The approval is primarily based on the results of two Phase III studies, VIALE-A and VIALE-C

Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis

AbbVie will provide $30 million over three years

I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…

The partnership will initially focus on the discovery of novel small molecules, targeting inflammatory and autoimmune diseases,…

The transaction significantly expands and diversifies AbbVie’s revenue base and complements existing leadership positions in…

Novartis, Merck and Allergan Plc were among companies that raised US prices on more than 100 prescription medicines on Friday,…